Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

5-[1-(2,6-dichlorobenzyl)piperidin-4-ylmethoxy]quinazoline-2,4-diamine dihydrochloride

EU orphan designation number: EU/3/11/892   
Active ingredient: 5-[1-(2,6-dichlorobenzyl)piperidin-4-ylmethoxy]quinazoline-2,4-diamine dihydrochloride
Indication: Treatment of 5q spinal muscular atrophy
Sponsor: Repligen Europe Limited
25/28 North Wall Quay, Dublin 1, Dublin Co., Ireland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/09/2011 Centralised Orphan - Designation EMA/OD/009/11 (2011)6278 of 30/08/2011